Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 35 | 2023 | 3065 | 3.680 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 11 | 2023 | 235 | 2.220 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 7 | 2022 | 519 | 1.940 |
Why?
|
Neuromyelitis Optica | 10 | 2019 | 249 | 1.690 |
Why?
|
Spinal Cord | 13 | 2020 | 1818 | 1.330 |
Why?
|
Axons | 10 | 2021 | 1689 | 0.950 |
Why?
|
Diffusion Magnetic Resonance Imaging | 13 | 2022 | 2732 | 0.920 |
Why?
|
Corpus Callosum | 3 | 2022 | 739 | 0.750 |
Why?
|
Cognitive Reserve | 1 | 2020 | 75 | 0.720 |
Why?
|
Atrophy | 7 | 2023 | 1571 | 0.600 |
Why?
|
Brain Mapping | 3 | 2018 | 6666 | 0.580 |
Why?
|
Brain | 16 | 2023 | 26345 | 0.560 |
Why?
|
Neural Pathways | 2 | 2018 | 2976 | 0.550 |
Why?
|
Magnetic Resonance Imaging | 27 | 2023 | 35326 | 0.540 |
Why?
|
Rest | 1 | 2020 | 904 | 0.530 |
Why?
|
Phosphodiesterase Inhibitors | 4 | 2021 | 215 | 0.500 |
Why?
|
Disability Evaluation | 6 | 2022 | 1824 | 0.490 |
Why?
|
Diffusion Tensor Imaging | 8 | 2020 | 2301 | 0.450 |
Why?
|
Leukoencephalitis, Acute Hemorrhagic | 1 | 2011 | 16 | 0.400 |
Why?
|
Pyridines | 6 | 2021 | 2810 | 0.400 |
Why?
|
Retrograde Degeneration | 1 | 2011 | 8 | 0.400 |
Why?
|
Postpartum Period | 1 | 2017 | 1070 | 0.390 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2010 | 114 | 0.370 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2012 | 964 | 0.340 |
Why?
|
Autoantibodies | 3 | 2020 | 2020 | 0.330 |
Why?
|
Nerve Net | 1 | 2020 | 2179 | 0.320 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2017 | 3344 | 0.310 |
Why?
|
Cerebral Cortex | 2 | 2020 | 5721 | 0.290 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2022 | 8977 | 0.270 |
Why?
|
Adult | 41 | 2022 | 213394 | 0.260 |
Why?
|
Immunologic Factors | 2 | 2017 | 1571 | 0.260 |
Why?
|
Myelin Sheath | 5 | 2023 | 664 | 0.240 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2867 | 0.230 |
Why?
|
Antibody Formation | 1 | 2007 | 1398 | 0.210 |
Why?
|
Middle Aged | 32 | 2022 | 212863 | 0.200 |
Why?
|
Internationality | 2 | 2019 | 1004 | 0.200 |
Why?
|
Cerebellum | 2 | 2019 | 1515 | 0.190 |
Why?
|
Humans | 60 | 2023 | 739398 | 0.190 |
Why?
|
Male | 35 | 2022 | 349022 | 0.180 |
Why?
|
Female | 38 | 2022 | 378853 | 0.180 |
Why?
|
Aquaporin 4 | 2 | 2009 | 153 | 0.150 |
Why?
|
Immunoglobulin G | 1 | 2009 | 4522 | 0.150 |
Why?
|
Young Adult | 14 | 2022 | 56255 | 0.150 |
Why?
|
Pattern Recognition, Automated | 2 | 2014 | 1000 | 0.150 |
Why?
|
Nerve Fibers | 1 | 2020 | 689 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 646 | 0.130 |
Why?
|
Pyrimidines | 2 | 2019 | 2918 | 0.130 |
Why?
|
Retina | 3 | 2020 | 2633 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2023 | 2303 | 0.130 |
Why?
|
Cerebral Veins | 1 | 2016 | 156 | 0.130 |
Why?
|
Microglia | 2 | 2023 | 1248 | 0.130 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7897 | 0.130 |
Why?
|
Receptors, GABA | 1 | 2016 | 287 | 0.130 |
Why?
|
Positron-Emission Tomography | 6 | 2023 | 6361 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2021 | 19811 | 0.120 |
Why?
|
Inflammation | 4 | 2019 | 10534 | 0.120 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4663 | 0.120 |
Why?
|
Optic Neuritis | 2 | 2020 | 164 | 0.110 |
Why?
|
Nerve Regeneration | 1 | 2019 | 795 | 0.110 |
Why?
|
Chemokine CXCL13 | 1 | 2013 | 54 | 0.110 |
Why?
|
Models, Neurological | 2 | 2019 | 1769 | 0.110 |
Why?
|
Image Enhancement | 2 | 2014 | 2928 | 0.110 |
Why?
|
Disease Progression | 7 | 2020 | 13237 | 0.110 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9259 | 0.110 |
Why?
|
Diplopia | 1 | 2013 | 194 | 0.100 |
Why?
|
Pain, Intractable | 1 | 2012 | 129 | 0.100 |
Why?
|
Vertigo | 1 | 2013 | 200 | 0.100 |
Why?
|
Spinal Cord Diseases | 1 | 2013 | 300 | 0.090 |
Why?
|
Tomography, Optical Coherence | 3 | 2020 | 2623 | 0.090 |
Why?
|
Sensitivity and Specificity | 4 | 2014 | 14740 | 0.090 |
Why?
|
Medication Adherence | 1 | 2021 | 2047 | 0.090 |
Why?
|
Myelin Proteins | 1 | 2010 | 218 | 0.090 |
Why?
|
Paraparesis | 1 | 2009 | 13 | 0.090 |
Why?
|
Methylprednisolone | 1 | 2011 | 388 | 0.090 |
Why?
|
Mothers | 1 | 2020 | 2143 | 0.090 |
Why?
|
Wallerian Degeneration | 1 | 2009 | 70 | 0.080 |
Why?
|
Optic Nerve | 2 | 2009 | 558 | 0.080 |
Why?
|
Electrodiagnosis | 1 | 2009 | 154 | 0.080 |
Why?
|
Headache | 2 | 2018 | 1199 | 0.080 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2881 | 0.080 |
Why?
|
Muscle Weakness | 1 | 2011 | 412 | 0.080 |
Why?
|
Interferon-beta | 1 | 2009 | 322 | 0.080 |
Why?
|
Selection Bias | 1 | 2009 | 370 | 0.080 |
Why?
|
Adolescent | 6 | 2021 | 85405 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2014 | 2373 | 0.080 |
Why?
|
Consensus | 1 | 2016 | 2913 | 0.080 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15036 | 0.080 |
Why?
|
Nerve Degeneration | 1 | 2012 | 759 | 0.070 |
Why?
|
Aging | 2 | 2019 | 8613 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3863 | 0.070 |
Why?
|
Evoked Potentials, Visual | 1 | 2009 | 427 | 0.070 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2270 | 0.070 |
Why?
|
Anthropometry | 2 | 2021 | 1344 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8307 | 0.070 |
Why?
|
Risk | 1 | 2017 | 9684 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3739 | 0.060 |
Why?
|
Computer Simulation | 1 | 2018 | 6237 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2007 | 536 | 0.060 |
Why?
|
Brain Diseases | 1 | 2013 | 1551 | 0.060 |
Why?
|
Complement System Proteins | 1 | 2007 | 799 | 0.060 |
Why?
|
Immunoglobulins | 1 | 2007 | 881 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3301 | 0.060 |
Why?
|
Aged | 10 | 2022 | 162698 | 0.060 |
Why?
|
Prospective Studies | 4 | 2020 | 53037 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2017 | 4026 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2009 | 1516 | 0.060 |
Why?
|
Chemokines | 1 | 2007 | 948 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12948 | 0.050 |
Why?
|
Visual Pathways | 2 | 2020 | 566 | 0.050 |
Why?
|
Environment | 1 | 2007 | 1110 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2017 | 4426 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2021 | 173 | 0.050 |
Why?
|
Electronics | 1 | 2021 | 322 | 0.040 |
Why?
|
Plasmapheresis | 1 | 2020 | 212 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2011 | 2627 | 0.040 |
Why?
|
Pregnancy | 2 | 2020 | 29002 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7274 | 0.040 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 316 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2012 | 15511 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2007 | 1086 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4395 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2013 | 21694 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4143 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 40389 | 0.030 |
Why?
|
Thalamus | 1 | 2020 | 1020 | 0.030 |
Why?
|
Anisotropy | 1 | 2017 | 1265 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6133 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2018 | 11985 | 0.030 |
Why?
|
Research Design | 2 | 2021 | 5959 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57650 | 0.030 |
Why?
|
Algorithms | 3 | 2019 | 13872 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3151 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1162 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2017 | 1539 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3757 | 0.020 |
Why?
|
Neural Conduction | 1 | 2009 | 469 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2013 | 24714 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2012 | 972 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9133 | 0.020 |
Why?
|
Quality Improvement | 1 | 2021 | 3730 | 0.020 |
Why?
|
Retinal Ganglion Cells | 1 | 2009 | 761 | 0.010 |
Why?
|
Quality of Life | 2 | 2016 | 12640 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13880 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3419 | 0.010 |
Why?
|
United States | 2 | 2021 | 69573 | 0.010 |
Why?
|
Child | 2 | 2020 | 77033 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10208 | 0.010 |
Why?
|
Depression | 1 | 2018 | 7689 | 0.010 |
Why?
|
Infant | 1 | 2020 | 34923 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62693 | 0.010 |
Why?
|
Prognosis | 1 | 2009 | 28901 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 76631 | 0.000 |
Why?
|
Animals | 1 | 2015 | 168368 | 0.000 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_